Edgewise Therapeutics Inc. Common Stock vs Mondaycom Ltd — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.3 (market cap $4.02B), while Mondaycom Ltd trades at $86.53 (market cap $3.70B). The key difference: Edgewise Therapeutics Inc. Common Stock and Mondaycom Ltd are close in size by market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Mondaycom Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Mondaycom Ltd for 16 Days on average.
| EWTX | MNDY | |
|---|---|---|
Market Cap | $4.02B | $3.70B |
Volume | 1,446,128 | 948,435 |
Sector | Health | Technology |
52-Week High | $48.35 | $205.24 |
52-Week Low | $14.89 | $58.81 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $3.56B | $2.87B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Monday.com (MNDY) trades at $84.69, down 0.08% on the day, with technical indicators showing a neutral bias amid mixed moving average signals. The company demonstrates strong fundamentals with consistent earnings beats, including Q2 2026 EPS of $1.48 versus $1.11 expected, and maintains robust profitability with an 88.74% gross margin. Recent news highlights inclusion in growth stock lists and AI-focused developments at the upcoming Elevate '26 conference.
The stock presents a compelling growth opportunity with a consensus price target of $108.64, implying 28% upside, supported by bullish analyst sentiment (61.5% buy ratings). Key risks include elevated valuation multiples (P/E 37.13) and competitive pressures in enterprise software. Positive cash flow generation and enterprise client growth momentum underpin the investment case, though investors should monitor execution on AI initiatives and margin sustainability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →